Learn More
Medchemexpress LLC 1-[4-[6-methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]piperazine | 1627503-67-6 | MFCD28168043 | 99.5% | 419.52 g/mol | C25H29N3O3 | 10 MG

Supplier: Medchemexpress LLC HY1671210MG
LDN-214117 is a selective small-molecule inhibitor of Activin receptor-like kinase 2 (ALK2/ACVR1) used in research to modulate BMP/TGF-β signaling. It is orally active, shows brain penetration, and demonstrates nanomolar potency against ALK2, making it suitable for biochemical and cellular studies and kinase target validation.
- Nanomolar potency against ALK2 (IC50 24 nM).
- High selectivity over related receptors (for example, >100-fold vs ALK5).
- Purity 99.54% by HPLC.
- Available as solid (including 5 mg and 10 mg) and as a 10 mM solution in DMSO.
- Suitable for biochemical and cellular BMP/TGF-β pathway studies.
- Certificate of analysis and safety data sheet available.
- Recommended storage: powder at -20°C; solutions at -80°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.